Brinkmann, V. et al. Neutrophil extracellular traps kill micro organism. Science 303, 1532–1535 (2004).
Sorvillo, N. et al. Extracellular DNA NET-works with dire penalties for well being. Circ. Res. 125, 470–488 (2019).
Albadawi, H. et al. Impact of DNase I therapy and neutrophil depletion on acute limb ischemia-reperfusion harm in mice. J. Vasc. Surg. 64, 484–493 (2016).
Ramacciotti, E. et al. P-selectin/PSGL-1 inhibitors versus enoxaparin within the decision of venous thrombosis: a meta-analysis. Thromb. Res. 125, e138–e142 (2010).
Kim, Okay. et al. NOX2 is essential for heterotypic neutrophil-platelet interactions throughout vascular irritation. Blood 126, 1952–1964 (2015).
Li, P. et al. PAD4 is crucial for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207, 1853–1862 (2010).
Cho, H. et al. Insulin resistance and a diabetes mellitus-like syndrome in mice missing the protein kinase Akt2 (PKB beta). Science 292, 1728–1731 (2001).
Ridker, P. M. et al. Antiinflammatory remedy with canakinumab for atherosclerotic illness. N. Engl. J. Med. 377, 1119–1131 (2017).
Xu, L. et al. Heterobivalent ligands goal cell-surface receptor combos in vivo. Proc. Natl Acad. Sci. USA 109, 21295–21300 (2012).
Gunawan, R. C., Almeda, D. & Auguste, D. T. Complementary concentrating on of liposomes to IL-1α and TNF-α activated endothelial cells through the transient expression of VCAM1 and E-selectin. Biomaterials 32, 9848–9853 (2011).
Sapra, P. & Allen, T. M. Improved consequence when B-cell lymphoma is handled with combos of immunoliposomal anticancer medicine focused to each the CD19 and CD20 epitopes. Clin. Most cancers Res. 10, 2530–2537 (2004).
Kanapathipillai, M., Brock, A. & Ingber, D. E. Nanoparticle concentrating on of anti-cancer medicine that alter intracellular signaling or affect the tumor microenvironment. Adv. Drug Deliv. Rev. 79, 107–118 (2014).
Anselmo, A. C. et al. Platelet-like nanoparticles: mimicking form, flexibility, and floor biology of platelets to focus on vascular accidents. ACS Nano 8, 11243–11253 (2014).
Wang, Z. et al. Prevention of vascular irritation by nanoparticle concentrating on of adherent neutrophils. Nat. Nanotechnol. 9, 204–210 (2014).
Chu, D. et al. Nanoparticle concentrating on of neutrophils for improved most cancers immunotherapy. Adv. Healthc. Mater. 5, 1088–1093 (2016).
Robertson, J. D. et al. Concentrating on neutrophilic irritation utilizing polymersome-mediated mobile supply. J. Immunol. 198, 3596–3604 (2017).
Liou, T. G. & Campbell, E. J. Nonisotropic enzyme–inhibitor interactions: a novel nonoxidative mechanism for quantum proteolysis by human neutrophils. Biochemistry 34, 16171–16177 (1995).
Owen, C. A. et al. Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and protect catalytic exercise of serine proteinases. J. Cell Biol. 131, 775–789 (1995).
Stenberg, P. E. et al. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J. Cell Biol. 101, 880–886 (1985).
Elliott, P. R. et al. Inhibitory conformation of the reactive loop of α1-antitrypsin. Nat. Struct. Biol. 3, 676–681 (1996).
Elliott, P. R. et al. Topography of a 2.0 Å construction of α1-antitrypsin reveals targets for rational drug design to forestall conformational illness. Protein Sci. 9, 1274–1281 (2000).
Forsyth, S., Horvath, A. & Coughlin, P. A overview and comparability of the murine α1-antitrypsin and α1-antichymotrypsin multigene clusters with the human clade A serpins. Genomics 81, 336–345 (2003).
Gehrig, S., Mall, M. A. & Schultz, C. Spatially resolved monitoring of neutrophil elastase exercise with ratiometric fluorescent reporters. Angew. Chem. Int. Ed. 51, 6258–6261 (2012).
Beatty, Okay., Bieth, J. & Travis, J. Kinetics of affiliation of serine proteinases with native and oxidized α-1-proteinase inhibitor and α-1-antichymotrypsin. J. Biol. Chem. 255, 3931–3934 (1980).
Appeldoorn, C. C. et al. Rational optimization of a brief human P-selectin-binding peptide results in nanomolar affinity antagonists. J. Biol. Chem. 278, 10201–10207 (2003).
Modery, C. L. et al. Heteromultivalent liposomal nanoconstructs for enhanced concentrating on and shear-stable binding to energetic platelets for site-selective vascular drug supply. Biomaterials 32, 9504–9514 (2011).
Daley, J. M. et al. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83, 64–70 (2008).
Elliott, J. T. & Prestwich, G. D. Maleimide-functionalized lipids that anchor polypeptides to lipid bilayers and membranes. Bioconjug. Chem. 11, 832–841 (2000).
Zhang, H. Skinny-film hydration adopted by extrusion technique for liposome preparation. Strategies Mol. Biol. 1522, 17–22 (2017).
Hope, M. J. et al. Discount of liposome measurement and preparation of unilamellar vesicles by extrusion strategies. Liposome Technol. 1, 123–139 (1993).
Bennewitz, M. F. et al. Lung vaso-occlusion in sickle cell illness mediated by arteriolar neutrophil-platelet microemboli. JCI Perception 2, e89761 (2017).
von Bruhl, M. L. et al. Monocytes, neutrophils, and platelets cooperate to provoke and propagate venous thrombosis in mice in vivo. J. Exp. Med. 209, 819–835 (2012).
Martinod, Okay. et al. Neutrophil histone modification by peptidylarginine deiminase 4 is essential for deep vein thrombosis in mice. Proc. Natl Acad. Sci. USA 110, 8674–8679 (2013).
Middleton, E. A. et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory misery syndrome. Blood 136, 1169–1179 (2020).
Lehmann, M. et al. Platelets drive thrombus propagation in a hematocrit and glycoprotein VI–dependent method in an in vitro venous thrombosis mannequin. Arterioscler. Thromb. Vasc. Biol. 38, 1052–1062 (2018).
Ramacciotti, E. et al. Analysis of soluble P-selectin as a marker for the prognosis of deep venous thrombosis. Clin. Appl. Thromb. Hemost. 17, 425–431 (2011).
Dyer, M. R. et al. Platelet-derived extracellular vesicles launched after trauma promote hemostasis and contribute to DVT in mice. J. Thromb. Haemost. 17, 1733–1745 (2019).
Bhattacharya, A. et al. Autophagy is required for neutrophil-mediated irritation. Cell Rep. 12, 1731–1739 (2015).
Melles, R. B. & Marmor, M. F. The danger of poisonous retinopathy in sufferers on long-term hydroxychloroquine remedy. JAMA Ophthalmol. 132, 1453–1460 (2014).
Mercuro, N. J. et al. Threat of QT interval prolongation related to use of hydroxychloroquine with or with out concomitant azithromycin amongst hospitalized sufferers testing optimistic for coronavirus illness 2019 (COVID-19). JAMA Cardiol. 9, 1036–1041 (2020).
Sames, E., Paterson, H. & Li, C. Hydroxychloroquine-induced agranulocytosis in a affected person with long-term rheumatoid arthritis. Eur. J. Rheumatol. 3, 91–92 (2016).
Castanheira, F. V. S. & Kubes, P. Neutrophils and NETs in modulating acute and persistent irritation. Blood 133, 2178–2185 (2019).
Silvestre-Roig, C. et al. Neutrophil variety in well being and illness. Developments Immunol. 40, 565–583 (2019).
Djie, M. Z., Stone, S. R. & Le Bonniec, B. F. Intrinsic specificity of the reactive website loop of α1-antitrypsin, α1-antichymotrypsin, antithrombin III, and protease nexin I. J. Biol. Chem. 272, 16268–16273 (1997).
Peiser, L., Mukhopadhyay, S. & Gordon, S. Scavenger receptors in innate immunity. Curr. Opin. Immunol. 14, 123–128 (2002).
Lahoz-Beneytez, J. et al. Human neutrophil kinetics: modeling of steady isotope labeling knowledge helps quick blood neutrophil half-lives. Blood 127, 3431–3438 (2016).
Bulbake, U. et al. Liposomal formulations in scientific use: an up to date overview. Pharmaceutics 9, 12 (2017).
Branzk, N. et al. Neutrophils sense microbe measurement and selectively launch neutrophil extracellular traps in response to massive pathogens. Nat. Immunol. 15, 1017–1025 (2014).
Pawlowski, C. L. et al. Platelet microparticle-inspired clot-responsive nanomedicine for focused fibrinolysis. Biomaterials 128, 94–108 (2017).
Stavrou, E. X. et al. Issue XII and uPAR upregulate neutrophil features to affect wound therapeutic. J. Clin. Make investments. 128, 944–959 (2018).
Stavrou, E. X. et al. Host and tumor issue XII drive ovarian most cancers upkeep and development. Blood 134, 2384–2384 (2019).
Englert, H. et al. Faulty NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation. EBioMedicine 67, 103382 (2021).